Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (14716)
All Articles published online
|
Jul 7, 2015 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Reshetnyak VI. Primary biliary cirrhosis: Clinical and laboratory criteria for its diagnosis. World J Gastroenterol 2015; 21(25): 7683-7708 [PMID: 26167070 DOI: 10.3748/wjg.v21.i25.7683] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i25/7683.htm |
| Number | Citing Articles |
| 1 |
Makayla Watt, John C Spence, Puneeta Tandon. Development of a Theoretically Informed Web-Based Mind-Body Wellness Intervention for Patients With Primary Biliary Cholangitis: Formative Study. JMIR Formative Research 2021; 5(10): e29064 doi: 10.2196/29064
|
| 2 |
Eleni Karatza, Brandon Swift, Fernando Carreño, Sumanta Mukherjee, Linda Casillas, Janelle Lennie, James Fettiplace, Megan M. McLaughlin, Andreas E. Kremer. Serum bile acid change correlates with improvement in pruritus in patients with primary biliary cholangitis receiving linerixibat. Liver International 2024; 44(9): 2293 doi: 10.1111/liv.15982
|
| 3 |
Yuli Wang, Zhenguo Huang, Jieping Lei, Xin Lu, Sizhao Li, Guochun Wang, Sheng Xie, Lu Zhang. Fatty infiltration in the posterior muscles of the lower extremities as an MRI feature in antimitochondrial antibody–associated myopathy. Clinical Rheumatology 2024; 43(3): 1127 doi: 10.1007/s10067-024-06877-9
|
| 4 |
Felix Harder, Fabian K. Lohöfer, Georgios A. Kaissis, Christoph Zoellner, Omar Kamal, Christoph Katemann, Andreas Hock, Julien Senegas, Johannes M. Peeters, Ernst J. Rummeny, Dimitrios Karampinos, Rickmer F. Braren. Camera-based respiratory triggering improves the image quality of 3D magnetic resonance cholangiopancreatography. European Journal of Radiology 2019; 120: 108675 doi: 10.1016/j.ejrad.2019.108675
|
| 5 |
Adnan Malik, Ani A. Kardashian, Kais Zakharia, Christopher L. Bowlus, James H. Tabibian. Preventative care in cholestatic liver disease: Pearls for the specialist and subspecialist. Liver Research 2019; 3(2): 118 doi: 10.1016/j.livres.2019.04.001
|
| 6 |
Kangjie Yu, Peifeng Li, Tianqi Xu, Junpeng Xu, Kaijing Wang, Jia Chai, Danhui Zhao, Yixiong Liu, Yingmei Wang, Jing Ma, Linni Fan, Shuangping Guo, Zengshan Li, Mingyang Li, Zhe Wang. Decreased infiltration of CD4+ Th1 cells indicates a good response to ursodeoxycholic acid (UDCA) in primary biliary cholangitis. Pathology - Research and Practice 2021; 217: 153291 doi: 10.1016/j.prp.2020.153291
|
| 7 |
Cody Kern, Ahmed Elmoursi, Caroline Blake, Andrew Hoellein. Syphilis Hepatitis Presenting as a Mimic of Primary Biliary Cholangitis. ACG Case Reports Journal 2020; 7(12): e00497 doi: 10.14309/crj.0000000000000497
|
| 8 |
Yuan Zhang, Xing Hu, Jing Chang, Jie Chen, Xue Han, Tieying Zhang, Jianjun Shen, Ning Shang, Jing Han, Hui Wang, Weiwei Kang, Fankun Meng. The liver steatosis severity and lipid characteristics in primary biliary cholangitis. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01974-4
|
| 9 |
Yuwei Chen, Lin Bai, Yongjie Zhou, Xiaoyun Zhang, Jie Zhang, Yujun Shi. Fine-scale visualizing the hierarchical structure of mouse biliary tree with fluorescence microscopy method. Bioscience Reports 2020; 40(5) doi: 10.1042/BSR20193757
|
| 10 |
Biljana Radovanović-Dinić, Snežana Tešić-Rajković, Valentina Zivkovic, Saša Grgov. Clinical connection between rheumatoid arthritis and liver damage. Rheumatology International 2018; 38(5): 715 doi: 10.1007/s00296-018-4021-5
|
| 11 |
Marlyn J. Mayo, Paul J. Pockros, David Jones, Christopher L. Bowlus, Cynthia Levy, Imran Patanwala, Bruce Bacon, Velimir Luketic, Raj Vuppalanchi, Sharon Medendorp, Alejandro Dorenbaum, Ciara Kennedy, Patricia Novak, Joan Gu, George Apostol, Gideon M. Hirschfield. A Randomized, Controlled, Phase 2 Study of Maralixibat in the Treatment of Itching Associated With Primary Biliary Cholangitis. Hepatology Communications 2019; 3(3): 365 doi: 10.1002/hep4.1305
|
| 12 |
Pietro Invernizzi, Marco Carbone, David Jones, Cynthia Levy, Nicola Little, Philippe Wiesel, Frederik Nevens. Setanaxib, a first‐in‐class selective NADPH oxidase 1/4 inhibitor for primary biliary cholangitis: A randomized, placebo‐controlled, phase 2 trial. Liver International 2023; 43(7): 1507 doi: 10.1111/liv.15596
|
| 13 |
Keisaku Sato, Shannon Glaser, Lindsey Kennedy, Suthat Liangpunsakul, Fanyin Meng, Heather Francis, Gianfranco Alpini. Preclinical insights into cholangiopathies: disease modeling and emerging therapeutic targets. Expert Opinion on Therapeutic Targets 2019; 23(6): 461 doi: 10.1080/14728222.2019.1608950
|
| 14 |
Eleanor Roberts. The Evolution of Pruritus Management for People with Primary Biliary Cholangitis. EMJ Hepatology 2024; : 2 doi: 10.33590/emjhepatol/11000003
|
| 15 |
Eunhee Han, Sung Jin Jo, Hyeyoung Lee, Ae-Ran Choi, Jihyang Lim, Eun-Sun Jung, Eun-Jee Oh. Clinical relevance of combined anti-mitochondrial M2 detection assays for primary biliary cirrhosis. Clinica Chimica Acta 2017; 464: 113 doi: 10.1016/j.cca.2016.11.021
|
| 16 |
Keisaku Sato, Shannon Glaser, Heather Francis, Gianfranco Alpini. Concise Review: Functional Roles and Therapeutic Potentials of Long Non-coding RNAs in Cholangiopathies. Frontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.00048
|
| 17 |
Debjyoti Kundu, Lindsey Kennedy, Vik Meadows, Leonardo Baiocchi, Gianfranco Alpini, Heather Francis. The Dynamic Interplay Between Mast Cells, Aging/Cellular Senescence, and Liver Disease. Gene Expression 2020; 20(2): 77 doi: 10.3727/105221620X15960509906371
|
| 18 |
Lei Dai, Yunyan Ye, Joseph Mugaany, Zetong Hu, Jing Huang, Changjiang Lu. Leveraging pQTL-based Mendelian randomization to identify new treatment prospects for primary biliary cholangitis and primary sclerosing cholangitis. Aging 2024; 16(10): 9228 doi: 10.18632/aging.205867
|
| 19 |
Natalia M. Krajewska, Rémi Fiancette, Ye H. Oo. Interplay between Mast Cells and Regulatory T Cells in Immune-Mediated Cholangiopathies. International Journal of Molecular Sciences 2022; 23(11): 5872 doi: 10.3390/ijms23115872
|
| 20 |
Max Kabolowsky, Lyndsey Nguyen, Brett E. Fortune, Ernesto Santos, Sirish Kishore, Juan C. Camacho. Interventional Management of Portal Hypertension in Cancer Patients. Current Oncology Reports 2022; 24(11): 1461 doi: 10.1007/s11912-022-01319-8
|
| 21 |
Despoina Dimopoulou, Theodoros Dimitroulas, Evangelos Akriviadis, Alexandros Garyfallos. Infliximab as a treatment option for patients with rheumatoid arthritis and primary biliary cirrhosis. Rheumatology International 2015; 35(11): 1913 doi: 10.1007/s00296-015-3366-2
|
| 22 |
Zobair M. Younossi, Maria Stepanova, Pegah Golabi, Robert S. Epstein, Marcie E. Strauss, Fatema Nader, Andrei Racila. Factors Associated With Potential Progressive Course of Primary Biliary Cholangitis. Journal of Clinical Gastroenterology 2019; 53(9): 693 doi: 10.1097/MCG.0000000000001120
|
| 23 |
Eleanor Roberts. Holistic Patient Care in Primary Biliary Cholangitis: Managing Both the Disease and the Symptoms. EMJ Hepatology 2022; : 22 doi: 10.33590/emjhepatol/10166227
|
| 24 |
Christopher L. Welle, Rachita Khot, Sudhakar K. Venkatesh, Raj Mohan Paspulati, Dhakshinamoorthy Ganeshan, Ann S. Fulcher. Benign biliary conditions with increased risk of malignant lesions. Abdominal Radiology 2024; doi: 10.1007/s00261-024-04630-z
|
| 25 |
Eleanor Roberts. Management of Cholestatic Pruritus in Primary Biliary Cholangitis: Ileal Bile Acid Transporter Inhibition and Holistic Care. EMJ Hepatology 2023; doi: 10.33590/emjhepatol/10307495
|
| 26 |
Mirna El Dirani, Julius M Nagaratnam, Samer Kholoki. Factors Explaining the Coincidence of Smoldering Multiple Myeloma and Primary Biliary Cholangitis: A Case Report. Cureus 2022; doi: 10.7759/cureus.26830
|
| 27 |
Yinghao Chang, Changcun Guo, Guanya Guo, Zhou Yuan, Xinmin Zhou, Jingbo Wang, Zheyi Han, Yu Chen, Gui Jia, Ying Han. Erythrocyte count is associated with prognosis in Chinese patients with primary biliary cholangitis. Experimental and Therapeutic Medicine 2020; doi: 10.3892/etm.2020.8446
|
| 28 |
Chunyang Huang, Weijia Han, Chuanmin Wang, Yanmin Liu, Yue Chen, Zhongping Duan. Early Prognostic Utility of Gp210 Antibody-Positive Rate in Primary Biliary Cholangitis: A Meta-Analysis. Disease Markers 2019; 2019: 1 doi: 10.1155/2019/9121207
|
| 29 |
Youyi Zhang, Jiabao Hu, Yuanbo Li, Weiwei Gu, Zukang Feng, Kaiheng Yan, Man Zhang, Yaya Li, Zi Yuan, Xiaomei Sun, Lu Zhang, Shanliang Xu, Yajun Wang, Xiaojun Yan. Identification of major histocompatibility complex II gene in Pampus argenteus and the expression pattern in Pampus argenteus kidney cell line under the pathogen stress. Aquaculture 2024; 592: 741249 doi: 10.1016/j.aquaculture.2024.741249
|
| 30 |
Tarika Sivakumar, Kris V Kowdley. Anxiety and Depression in Patients with Primary Biliary Cholangitis: Current Insights and Impact on Quality of Life. Hepatic Medicine: Evidence and Research 2021; : 83 doi: 10.2147/HMER.S256692
|
| 31 |
Rakesh Sahu, Rakhi Mishra, Chandana Majee. An insight into primary biliary cholangitis and its recent advances in treatment: semi-synthetic analogs to combat ursodeoxycholic-acid resistance. Expert Review of Gastroenterology & Hepatology 2020; 14(10): 985 doi: 10.1080/17474124.2020.1797485
|
| 32 |
Seik-Soon Khor, Kazuko Ueno, Nao Nishida, Minae Kawashima, Yosuke Kawai, Yoshihiro Aiba, Yuki Hitomi, Masao Nagasaki, Minoru Nakamura, Katsushi Tokunaga. Novel HLA allele associations with susceptibility, staging, symptomatic state, autoimmune hepatitis and hepatocellular carcinoma events for primary biliary cholangitis in the Japanese population. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1151502
|
| 33 |
Chunhui She, Yifei Yang, Bo Zang, Yuan Yao, Qixuan Liu, Patrick S. C. Leung, Bin Liu. Effect of LncRNA XIST on Immune Cells of Primary Biliary Cholangitis. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.816433
|
| 34 |
Carla F. Murillo Perez, Maren H. Harms, Keith D. Lindor, Henk R. van Buuren, Gideon M. Hirschfield, Christophe Corpechot, Adriaan J. van der Meer, Jordan J. Feld, Aliya Gulamhusein, Willem J. Lammers, Cyriel Y. Ponsioen, Marco Carbone, Andrew L. Mason, Marlyn J. Mayo, Pietro Invernizzi, Pier Maria Battezzati, Annarosa Floreani, Ana Lleo, Frederik Nevens, Kris V. Kowdley, Tony Bruns, George N. Dalekos, Nikolaos K. Gatselis, Douglas Thorburn, Palak J. Trivedi, Xavier Verhelst, Albert Parés, Harry L.A. Janssen, Bettina E. Hansen. Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase. American Journal of Gastroenterology 2020; 115(7): 1066 doi: 10.14309/ajg.0000000000000557
|
| 35 |
Vasiliy Ivanovich Reshetnyak, Igor Veniaminovich Maev. Pathophysiology of biochemical signs of primary biliary cholangitis. Exploration of Digestive Diseases 2023; : 149 doi: 10.37349/edd.2023.00024
|
| 36 |
Rania Naguib, Amel Fayed, Eman Elkemary, Hend Naguib. Serum Ghrelin Concentration in Patients With Primary Biliary Cirrhosis (PBC). Cureus 2021; doi: 10.7759/cureus.20288
|
| 37 |
Aleksandar Arsenijevic, C. Randall Harrell, Crissy Fellabaum, Vladislav Volarevic. Mesenchymal Stem Cells as New Therapeutic Agents for the Treatment of Primary Biliary Cholangitis. Analytical Cellular Pathology 2017; 2017: 1 doi: 10.1155/2017/7492836
|
| 38 |
Kai Markus Schneider, Martin Kummen, Palak J. Trivedi, Johannes R. Hov. Role of microbiome in autoimmune liver diseases. Hepatology 2024; 80(4): 965 doi: 10.1097/HEP.0000000000000506
|
| 39 |
Fei-fei Han, Ming-xia Fang, Dan-tong Zhao, Yi-chao Dong, Guo-hong Yuan, Jian-en Gao, Chang-long Guo. Profiling of the pattern of the human TRB/IGH–CDR3 repertoire in primary biliary cholangitis patients. International Immunopharmacology 2020; 83: 106393 doi: 10.1016/j.intimp.2020.106393
|
| 40 |
Vasiliy I. Reshetnyak, Igor V. Maev. Features of Lipid Metabolism Disorders in Primary Biliary Cholangitis. Biomedicines 2022; 10(12): 3046 doi: 10.3390/biomedicines10123046
|
| 41 |
Vasiliy Ivanovich Reshetnyak, Igor Veniaminovich Maev. New insights into the pathogenesis of primary biliary cholangitis asymptomatic stage. World Journal of Gastroenterology 2023; 29(37): 5292-5304 doi: 10.3748/wjg.v29.i37.5292
Abstract(571) |
Core Tip(616) |
Full Article(HTML)(2176)
|
Full Article with Cover (PDF)-5898K(107)
|
Full Article (Word)-2514K(53)
|
Audio-443K(8)
|
Peer-Review Report-225K(64)
|
Answering Reviewers-166K(68)
|
Full Article (PDF)-4290K(230)
|
Full Article (XML)-187K(55)
|
Times Cited (2)
|
Total Visits (5811)
|
Open
|
| 42 |
Raquel T. Yokoda, Elizabeth J. Carey. Primary Biliary Cholangitis and Primary Sclerosing Cholangitis. American Journal of Gastroenterology 2019; 114(10): 1593 doi: 10.14309/ajg.0000000000000268
|
| 43 |
Vasiliy Ivanovich Reshetnyak, Igor Veniaminovich Maev. Mechanism for development of malnutrition in primary biliary cholangitis. World Journal of Meta-Analysis 2022; 10(3): 81-98 doi: 10.13105/wjma.v10.i3.81
|
| 44 |
Yuehong Lao, Xi Li, Wei Zhou, Haiqing Zhu, Yanting Jiang, Sihui Li, Min Jin, Jian Wang. The clinical value of the monocyte to high-density lipoprotein cholesterol ratio and alkaline phosphatase-to-platelet ratio in primary biliary cholangitis. Medicine 2023; 102(41): e35454 doi: 10.1097/MD.0000000000035454
|
| 45 |
Saeam Shin, In Ho Moh, Young Sik Woo, Sung Won Jung, Jin Bae Kim, Ji Won Park, Ki Tae Suk, Hyoung Su Kim, Mineui Hong, Sang Hoon Park, Myung Seok Lee. Evidence from a familial case suggests maternal inheritance of primary biliary cholangitis. World Journal of Gastroenterology 2017; 23(39): 7191-7197 doi: 10.3748/wjg.v23.i39.7191
|
| 46 |
Takako Saeki, Akihiro Nakajima, Tomoyuki Ito, Takuma Takata, Naofumi Imai, Kazuhiro Yoshita, Hideyuki Kabasawa, Hajime Yamazaki, Ichiei Narita. Tubulointerstitial nephritis and Fanconi syndrome in a patient with primary Sjögren’s syndrome accompanied by antimitochondrial antibodies: A case report and review of the literature. Modern Rheumatology 2018; 28(5): 897 doi: 10.3109/14397595.2016.1174422
|
| 47 |
Vasiliy I. Reshetnyak, Igor V. Maev, Tatiana M. Reshetnyak, Sergei V. Zhuravel, Vladimir M. Pisarev. Liver Disease and Hemostasis (Review) Part 2. Cholestatic Liver Disease and Hemostasis. General Reanimatology 2019; 15(6): 80 doi: 10.15360/1813-9779-2019-6-80-93
|
| 48 |
Yuan Zhang, Xing Hu, Jing Chang, Weihua Li, Chunyang Huang, Haiping Zhang, Jianjun Shen, Ning Shang, Fankun Meng. Ultrasound imaging findings in primary biliary cholangitis. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-03083-w
|
| 49 |
Qi Wang, Xiaomeng Tang, Wenying Qiao, Lina Sun, Han Shi, Dexi Chen, Bin Xu, Yanmin Liu, Juan Zhao, Chunyang Huang, Ronghua Jin. Machine learning-based characterization of the gut microbiome associated with the progression of primary biliary cholangitis to cirrhosis. Microbes and Infection 2024; : 105368 doi: 10.1016/j.micinf.2024.105368
|
| 50 |
Tingwang Jiang, Xiaoli Xiang, Xudong Wang, Zhijun Han, Cuie Cheng, Yuehong Zhu, Zaixing Yang, Yan Liang. Regulatory T Cells and Autoimmune Diseases. 2024; : 433 doi: 10.1016/B978-0-443-13947-5.00014-2
|
| 51 |
Albert Parés, Mitchell Shiffman, Victor Vargas, Pietro Invernizzi, Elizabeth S. Malecha, Alexander Liberman, Leigh MacConell, Gideon Hirschfield. Reduction and stabilization of bilirubin with obeticholic acid treatment in patients with primary biliary cholangitis. Liver International 2020; 40(5): 1121 doi: 10.1111/liv.14429
|
| 52 |
Jose Melendez-Rosado, Ali Alsaad, Fernando F. Stancampiano, William C. Palmer. Abnormal Liver Enzymes. Gastroenterology Nursing 2018; 41(6): 497 doi: 10.1097/SGA.0000000000000346
|
| 53 |
C. Iking-Konert, W.-J. Mayet, S. Kuchen, J. Jenewein, S. Büchi, H. Zeidler, B. Michel. Differenzialdiagnose rheumatischer Erkrankungen. 2019; : 363 doi: 10.1007/978-3-662-56575-9_10
|
| 54 |
V. I. Reshetnyak, I. V. Maev. Dyslipidemia and its features in primary biliary cholangitis. Health care of Tajikistan 2023; (1): 119 doi: 10.52888/0514-2515-2023-356-1-119-130
|